Fatty liver disease (MASLD/MASH): open trials in Sweden

• NCT07312136

  MASLD in Type 2 Diabetes in Primary Care - a Follow-up Study

  Research · Linkoeping University

  Department of Gastroenterology and Hepatology, Linköping University Hospital, Linköping

  Registry updated 2026-10-09

• NCT07165028

  A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

  Trial Treatment · Phase 3 · Eli Lilly and Company

  Universitetssjukhuset i Linkoping, Linköping

  Registry updated 2026-10-08

• NCT06374875

  Fibrosis Lessens After Metabolic Surgery

  Trial Treatment · Phase 4 · The Cleveland Clinic

  Linköping University, Linköping · Örebro University, Örebro

  Registry updated 2026-07-31

• NCT06701968

  Effects of a Healthy Nordic Diet on Atherosclerosis in Patients with Coronary Heart Disease

  Trial Treatment · Uppsala University

  Cardiology clinic, Uppsala university hospital, Uppsala

  Registry updated 2025-03-06

• NCT04209816

  Genetic Pathways Leading to Fatty Liver and Atherogenic Dyslipidemia

  Research · Marja-Riitta Taskinen

  Wallenberg Laboratory, Gothenburg

  Registry updated 2023-09-22

• NCT04442334

  The European NAFLD Registry

  Research · Newcastle University

  Karolinska Universitetssjukhuset, Huddinge · Linkoping University Hospital, Linköping

  Registry updated 2023-01-06

All Fatty liver disease (MASLD/MASH) trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error